Rituximab Works in ANCA-Linked Vasculitis (CME/CE)

WASHINGTON (MedPage Today) -- Rituximab given as adjunctive therapy to children with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis dramatically lowered the dosage of cyclophosphamide needed for treatment, researchers said here.
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news